The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
This conference workshop provides comprehensive insights into the emerging trends, regulatory differences, and technological advancements in the Chinese pharmaceutical and healthcare sector.
1300 – 1310: Welcome by Ping ZHANG & Sophie PANG 1310 – 1330: Development of ISPE China in recent 3 years by Hongyang LI 1300 – 1400: Comparative Analysis of NMPA/FDA Regulations-Pathway to Entry Chinese Market Successfully by Ping ZHANG 1400 – 1430: Gene and Cell Therapy in China – landscape and regulatory update by Frank GAO 1430 – 1445: Break 1445 – 1515: Manufacturing Excellence on Biologics Products with Single Use Technology and Robust Quality Operations by Sherry GU 1515 – 1530: High performance and Cost-effective Bioprocess Solutions by Peter FU 1530 – 1600: QA/Closing